Skip to main content

PHIBRO ANIMAL HEALTH CORP

For the period ended Sep 30, 2025. Filed Nov 5, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 5, 2025

PAHC$34.61+5.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Consolidated Statements of Operations

​​​​​​​
​ · ​ · Three Months
For the Periods Ended September 30 · 2025 · 2024
​ · ​ · (unaudited)
​ · ​ · (in thousands, except per share amounts)
Net sales​$363,893​$260,432
Cost of goods sold​244,110​176,937
Gross profit​119,783​83,495
Selling, general and administrative expenses​68,523​65,796
Operating income​51,260​17,699
Interest expense, net​12,059​7,641
Foreign currency losses, net​2,934​438
Income before income taxes​36,267​9,620
Provision for income taxes​9,740​2,645
Net income​$26,527​$6,975
​​​​​​​
Net income per share​​
basic​$0.65​$0.17
diluted​$0.65​$0.17
Weighted average common shares outstanding​​​​
basic​40,534​40,504
diluted​​40,877​​40,582
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.